Scinovex
articleTop 1% cited

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

Annals of Oncology · 2013 · Vol. 24(9) · pp. 2278–2284
Andreas SchneeweißStephen ChiaTamas HickishV. HarveyAlexandru EniuRoberto HeggChristoph TauschJae Hong SeoY.-F. TsaiJayantha RatnayakeVirginia McNallyG. RossJavier Cortés
HER2/EGFR in Cancer ResearchCancer Treatment and PharmacologyBreast Cancer Treatment StudiesMedicineEpirubicinPertuzumabTrastuzumabBreast cancerInternal medicineAnthracyclineDocetaxelNeoadjuvant therapyChemotherapy

MeSH terms

TrastuzumabDocetaxelAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideFemaleFluorouracilHeartHumansStroke VolumeEpirubicinCarboplatinVentricular Function, LeftErb-b2 Receptor Tyrosine KinasesReceptor, ErbB-2

Funding

  • Roche
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.